Investigating CTL mediated killing with a 3D cellular automaton.
Cytotoxic T lymphocytes (CTLs) are important immune effectors against intra-cellular pathogens. These cells search for infected cells and kill them. Recently developed experimental methods in combination with mathematical models allow for the quantification of the efficacy of CTL killing in vivo and, hence, for the estimation of parameters that characterize the effect of CTL killing on the target cell populations. It is not known how these population-level parameters relate to single-cell properties. To address this question, we developed a three-dimensional cellular automaton model of the region of the spleen where CTL killing takes place. The cellular automaton model describes the movement of different cell populations and their interactions. Cell movement patterns in our cellular automaton model agree with observations from two-photon microscopy. We find that, despite the strong spatial nature of the kinetics in our cellular automaton model, the killing of target cells by CTLs can be described by a term which is linear in the target cell frequency and saturates with respect to the CTL levels. Further, we find that the parameters describing CTL killing on the population level are most strongly impacted by the time a CTL needs to kill a target cell. This suggests that the killing of target cells, rather than their localization, is the limiting step in CTL killing dynamics given reasonable frequencies of CTL. Our analysis identifies additional experimental directions which are of particular importance to interpret estimates of killing rates and could advance our quantitative understanding of CTL killing.
Graw
Frederik
F
Institute of Integrative Biology, ETH Zurich, Zurich, Switzerland. frederik.graw@env.ethz.ch
Regoes
Roland R
RR
D000465:Algorithms; D000818:Animals; D002465:Cell Movement / Q000276:immunology; D003198:Computer Simulation; D021621:Imaging, Three-Dimensional; D051379:Mice; D018448:Models, Immunological; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
J Exp Med. 2007 Mar 19;204(3):489-95
17325198
J Virol. 2004 Jun;78(11):5535-45
15140950
Bull Math Biol. 2000 Sep;62(5):869-90
11016088
Bull Math Biol. 1996 Jan;58(1):43-63
8819753
Science. 2002 Jun 7;296(5574):1869-73
12016203
J Immunol. 2008 Sep 15;181(6):3947-54
18768849
PLoS Biol. 2005 Jun;3(6):e150
15857154
J Immunol. 2008 Jan 1;180(1):291-9
18097030
Nat Rev Immunol. 2004 Aug;4(8):630-40
15286729
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10985-90
16832064
PLoS Comput Biol. 2006 Mar;2(3):e24
16604188
J Exp Med. 2004 Oct 4;200(7):847-56
15466619
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2604-9
12601158
Eur J Immunol. 2000 May;30(5):1356-63
10820382
Immunol Rev. 1997 Apr;156:11-24
9176696
Nature. 2004 Jan 8;427(6970):154-9
14712275
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):998-1003
14722354
J Immunol. 2003 Jul 1;171(1):27-31
12816979
Mol Cell Biol. 2008 Jun;28(12):4040-51
18426917
Immunol Rev. 1998 Aug;164:29-36
9795761
Immunol Cell Biol. 2008 Nov-Dec;86(8):676-87
18711399
Immunity. 2004 Sep;21(3):315-29
15357943
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1599-603
17242364
PLoS Biol. 2006 Apr;4(4):e90
16515366
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15323-8
8986810
Science. 2003 Dec 5;302(5651):1704-9
14657486
Immunol Cell Biol. 2007 Jun;85(4):306-14
17420768
Microvasc Res. 1987 Nov;34(3):269-89
3323854
PLoS One. 2007 Dec 12;2(12):e1301
18074025
Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Jul;74(1 Pt 1):011910
16907130
J Theor Biol. 1995 Aug 21;175(4):567-76
7475092
J Exp Med. 2007 Apr 16;204(4):771-80
17389236
Immunity. 2008 Sep 19;29(3):476-86
18760639
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4565-70
17360564
J Virol. 2008 Dec;82(23):11749-57
18815293
Nat Rev Immunol. 2002 Nov;2(11):872-80
12415310
Immunity. 2006 Jul;25(1):129-41
16860762